KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Clover Health Investments (CLOV) Other Non-Current Liabilities (2020 - 2025)

Clover Health Investments (CLOV) has disclosed Other Non-Current Liabilities for 6 consecutive years, with $25.3 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Other Non-Current Liabilities fell 12.5% year-over-year to $25.3 million, compared with a TTM value of $25.3 million through Sep 2025, down 12.5%, and an annual FY2024 reading of $26.1 million, up 12.61% over the prior year.
  • Other Non-Current Liabilities was $25.3 million for Q3 2025 at Clover Health Investments, down from $28.9 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $196.5 million in Q2 2021 and bottomed at $13.1 million in Q2 2022.
  • Average Other Non-Current Liabilities over 5 years is $32.8 million, with a median of $22.3 million recorded in 2024.
  • The sharpest move saw Other Non-Current Liabilities tumbled 93.35% in 2022, then skyrocketed 81.06% in 2024.
  • Year by year, Other Non-Current Liabilities stood at $14.1 million in 2021, then increased by 14.88% to $16.2 million in 2022, then skyrocketed by 43.04% to $23.2 million in 2023, then rose by 12.61% to $26.1 million in 2024, then dropped by 3.08% to $25.3 million in 2025.
  • Business Quant data shows Other Non-Current Liabilities for CLOV at $25.3 million in Q3 2025, $28.9 million in Q2 2025, and $32.0 million in Q1 2025.